India Treats Half a Million Foreign Patients. One Country Sends Nearly Two-Thirds
The family arrives with a thick folder.
It holds scans.
Blood tests.
Doctor notes.
A list of medicines.
They did not come to India for a new smile.
They did not come for a quick skin treatment.
Someone in the family is very sick.
That is what makes India different from many medical tourism giants.
Turkey is famous for hair and teeth.
South Korea sells skin care and plastic surgery.
Thailand mixes hospitals with wellness and holidays.
India sells hope to people who may have run out of choices at home.
Heart surgery.
Cancer care.
Organ transplants.
Brain surgery.
Joint replacement.
Treatment for a sick child.
These are hard cases. They can take weeks. Families may spend their savings to make the trip.
India recorded 507,244 foreign arrivals for medical treatment in 2025. That was about 5.5 percent of all foreign tourist arrivals during the year. The government valued India’s wider medical tourism market at about $8.7 billion and expects it to reach roughly $16.2 billion by 2030.
But India’s patient map has one big weakness.
It depends heavily on one country.
Bangladesh sent 325,127 medical travelers in 2025.
That was about 64 percent of India’s total.
No other country came close.
India’s Top 10 Medical Tourism Source Countries
| Rank | Country | 2025 medical arrivals |
|---|---|---|
| 1 | Bangladesh | 325,127 |
| 2 | Iraq | 30,989 |
| 3 | Uzbekistan | 13,699 |
| 4 | Somalia | 11,506 |
| 5 | Turkmenistan | 10,231 |
| 6 | Oman | 9,738 |
| 7 | Kenya | 9,357 |
| 8 | Nigeria | 8,251 |
| 9 | Maldives | 7,016 |
| 10 | Yemen | 5,969 |
The first seven countries come from official 2025 government data.
India has not released a full public ranking for the final three places.
Nigeria, Maldives and Yemen are included as the best estimate based on older government rankings, current hospital routes and their long history of sending patients to India. Tanzania, Sudan, Afghanistan and Uganda could also enter the bottom of the top 10 under a different dataset.
1. Bangladesh
Bangladesh is not just India’s largest medical tourism market.
It is the market.
In 2025, Bangladesh sent more than 10 times as many medical travelers as Iraq, which ranked second.
The patient road is easy to understand.
The countries share a long border.
Flights are short.
Many patients can reach India by road or train.
Language also helps. Bengali is spoken on both sides of the border.
A patient from Dhaka may feel more at home in Kolkata than in Bangkok, Kuala Lumpur or Singapore.
For years, Bangladeshi families have used Indian hospitals for cancer care, heart surgery, kidney treatment, orthopedics and difficult tests.
Kolkata is often the first stop.
It is close and familiar.
More complex cases may continue to Delhi, Chennai, Mumbai, Hyderabad or Bengaluru.
The route grew through trust.
One person received treatment in India.
Then a brother came.
Then a neighbor.
Then the local doctor began sending patients to the same hospital.
This is how a medical tourism road becomes hard to break.
Politics almost broke it
Bangladesh sent 499,951 medical travelers to India in 2023.
The number slipped to 482,336 in 2024.
It then fell to 325,127 in 2025—a drop of almost one-third in one year.
The main reason was not medicine.
It was politics.
India sharply cut visa services after the government of former Bangladeshi Prime Minister Sheikh Hasina fell in 2024. Medical visas were still issued for urgent cases, but the normal flow slowed.
Some patients waited.
Some gave up.
Others began looking at Thailand, Malaysia and China.
Reuters reported that the number of medical visas issued each day fell from thousands to fewer than 1,000 during the worst period. China saw a chance to take patients from India and began offering more medical access to Bangladeshis.
The effect was felt inside Indian hospitals.
Kolkata clinics lost patients.
Hotels lost guests.
Drivers lost airport pickups.
Pharmacies lost sales.
A political fight changed the flow of sick people.
That shows how dependent India has become on Bangladesh.
Bangladesh is India’s strength and risk
India has something other countries cannot copy easily.
It is next door.
It has years of patient stories.
It has hospitals that already understand Bangladeshi families.
But relying on one country for almost two-thirds of foreign medical arrivals is dangerous.
A visa rule can cut the market.
A border closure can cut the market.
A political dispute can cut the market.
China does not need to take every Bangladeshi patient.
Thailand does not need to take every patient.
They only need to make India feel less certain.
For years, India assumed the Bangladesh road would always stay open.
The fall in 2025 proved that it may not.
2. Iraq
Iraq sent 30,989 medical travelers to India in 2025.
That was less than one-tenth of the Bangladesh total.
But Iraqi patients may bring much larger hospital bills.
They often travel for serious care.
Cancer.
Heart surgery.
Brain treatment.
Orthopedics.
Organ transplants.
Care for children born with complex conditions.
An old Indian tourism report found that almost 95 percent of Iraqi arrivals in 2021 came for medical reasons. Around 90 percent entered through Delhi.
That tells us where the Iraqi patient road leads.
Delhi and the surrounding National Capital Region contain some of India’s largest private hospitals.
These hospitals have Arabic-speaking teams.
They review medical records before travel.
They prepare cost estimates.
They arrange airport pickup and help families find places to stay.
For an Iraqi family, India is often not the first medical choice.
It may be the choice after local treatment has failed.
The patient may already have seen several doctors.
The family may arrive scared, tired and short of money.
Price matters.
But trust matters more.
They need to believe the Indian hospital can do what the hospital at home could not.
Iraq is a hospital market, not a holiday market
An Iraqi patient is unlikely to build the trip around sightseeing.
The hospital comes first.
Family members may stay for weeks.
They need food, translation, transport and help with documents.
This creates a different business from a dental holiday.
The hospital must manage the whole family.
It must answer calls at night.
It must explain what happens next.
It must help when the treatment takes longer than planned.
India has learned how to do this.
That is why Iraq remains second even though Turkey, Jordan, Iran and other countries also want Iraqi patients.
3. Uzbekistan
Uzbekistan sent 13,699 medical travelers to India in 2025.
That was a sharp rise from 8,921 in 2024.
The growth shows India’s push into Central Asia is working.
Uzbek patients travel for heart care, cancer treatment, joint surgery, organ transplants, fertility treatment and care for children.
India competes with Turkey, Russia, South Korea and Germany for these patients.
Turkey may feel closer in language and culture.
Russia has old medical links.
South Korea has a strong technology brand.
Germany has status.
India wins on the mix.
It can offer a large hospital, an English-speaking doctor and a lower bill than many premium destinations.
Indian hospitals also market directly in Tashkent.
Doctors hold patient meetings.
Local agents collect scans.
Online appointments allow families to speak with a doctor before paying for a flight.
The sale often begins inside Uzbekistan.
By the time the patient reaches Delhi or Chennai, the hospital may already know the case.
Central Asia could reduce India’s Bangladesh risk
Uzbekistan will not replace Bangladesh soon.
The numbers are too small.
But Uzbekistan is part of a larger Central Asian market that includes Turkmenistan, Kazakhstan, Kyrgyzstan and Tajikistan.
Together, these countries can become a strong second patient road.
They have growing middle classes.
Some lack access to highly complex treatment.
Many patients already travel abroad.
India does not need to create the demand.
It needs to convince families to choose India over Turkey, Russia or South Korea.
4. Somalia
Somalia sent 11,506 medical travelers to India in 2025.
The growth of this route has been sudden.
Only 1,006 Somali medical travelers were recorded in 2022.
The number jumped to 15,947 in 2023 and stayed above 11,000 in both 2024 and 2025.
Somali patients often need care that is hard to find at home.
Cancer treatment.
Heart surgery.
Kidney care.
Orthopedics.
Neurological treatment.
Complex tests.
Many travel with a family member.
Some receive help from relatives living abroad.
Others sell property or borrow money.
This is not easy medical travel.
The patient may not speak English.
The family may have never left East Africa.
They may arrive in Delhi with little idea of how the city works.
That gives agents and facilitators great power.
A good agent can make the trip possible.
A bad one can add hidden fees, send the patient to the wrong hospital or disappear after taking payment.
Somalia’s rise is good news for Indian hospitals.
It also tests whether India can protect vulnerable patients.
5. Turkmenistan
Turkmenistan sent 10,231 medical travelers to India in 2025.
That placed it ahead of Oman and Kenya.
This is one of the newest stories in India’s patient map.
Turkmenistan did not appear among the government’s top five source markets in the 2024 ranking.
One year later, it was fifth.
Patients may travel for surgery, cancer care, heart treatment, fertility services and detailed health checks.
The market is helped by India’s wider push into Central Asia.
Indian hospitals attend events in the region.
They work with local medical travel firms.
They use Russian-speaking staff because Russian is still widely understood across parts of Central Asia.
Turkmenistan is a small country.
It will never produce Bangladesh-sized volume.
But 10,000 serious patients can still matter.
A heart operation or cancer case can be worth far more than a short clinic visit.
6. Oman
Oman sent 9,738 medical travelers to India in 2025.
It has been an important source market for years.
In 2023, Oman sent 13,397 patients. The number fell to 10,431 in 2024 and slipped again in 2025.
Omani patients often travel for heart care, cancer treatment, joint surgery, neurological care and complex procedures.
India has strong ties with Oman.
There is a large Indian community in the country.
Flights are frequent.
English is widely used in both business and private healthcare.
An Omani family may already know someone who received treatment in India.
That lowers fear.
The Gulf market is valuable because patients may spend more.
Some arrive with private insurance or government support.
They may choose private rooms and stay for long periods.
But India faces stronger competition than before.
Oman has improved its own hospitals.
Thailand has excellent Arabic patient services.
Turkey offers strong private hospitals closer to Europe.
Dubai is nearby.
India cannot depend only on a low price.
It must make the experience easier.
7. Kenya
Kenya sent 9,357 medical travelers to India in 2025.
The countries have deep business and family ties.
Kenya also has a large community of Indian origin.
Some Kenyan families have known Indian hospital names for years.
Patients travel for cancer care, heart surgery, kidney treatment, bone and joint surgery, fertility care and specialist tests.
South Africa, Turkey, the United Arab Emirates and local Kenyan hospitals all compete for these patients.
India’s main strength is the depth of care.
A patient can find many hospitals offering the same complex treatment.
That creates choice and keeps prices under pressure.
Indian doctors also travel to Kenya for medical camps and consultations.
The patient may meet the doctor in Nairobi before deciding to travel.
That first meeting can turn a foreign hospital into a trusted place.
Africa is becoming India’s second big chance
India wants more patients from Kenya, Nigeria, Tanzania, Ethiopia, Uganda and Zambia.
This is partly about growth.
It is also about protection.
Hospitals saw what happened when the Bangladesh flow collapsed.
They do not want one political event to empty their international patient departments again.
Africa offers a large pool of patients who need complex care.
But it is not an easy market.
Flights can be expensive.
Families may struggle with payment.
Visas can take time.
Aftercare is hard when the patient lives thousands of miles away.
The hospitals that solve those problems will win.
8. Nigeria
Nigeria’s exact 2025 medical arrival count has not been published in the latest government summary.
It still belongs in the estimated top 10.
Nigeria appeared among India’s leading medical source countries in earlier official data. Its share was close to 1 percent of all medical arrivals before the pandemic.
Nigeria is one of Africa’s largest countries.
It also has many wealthy families who travel abroad for treatment.
Patients seek cancer care, heart surgery, kidney treatment, fertility services, orthopedics and complex diagnosis.
India competes with Britain, the United States, Turkey, Germany, Dubai and South Africa.
Price gives India a strong opening.
Language helps too.
English is widely spoken in Nigeria and is the main language used in Indian medical education and many private hospitals.
But the Nigerian market has risks.
Patients may depend on brokers.
Payment fraud is a concern for hospitals.
Visa and travel costs can stop a case after the doctor has already reviewed it.
Nigeria has huge potential.
Turning potential into real patients takes work on the ground.
9. Maldives
Maldives is one of India’s oldest medical travel partners.
Its current rank is uncertain, but its healthcare link with India is clear.
In 2021, about 86 percent of Maldivian arrivals in India came for medical reasons.
More than 43 percent entered through Kochi.
The reason is geography.
Maldives has a small population spread across many islands.
It can provide everyday care.
It cannot offer every form of complex hospital treatment.
South India is close.
Kochi, Chennai and Bengaluru have large private hospitals and direct flight links.
Maldivian patients travel for heart care, cancer treatment, surgery, childbirth, children’s medicine and detailed tests.
Some cases are supported by public healthcare programs.
Others are privately paid.
The market is small in total population but large in medical need.
A country does not need millions of people to become an important medical source market.
It only needs to send a large share of its difficult cases abroad.
10. Yemen
Yemen completes the estimated top 10.
It was once a clear part of India’s leading medical market group.
Government figures showed that Yemen supplied about 2.4 percent of India’s foreign medical arrivals in 2017 and a similar share in 2019.
Years of war damaged Yemen’s healthcare system.
Patients who can travel may seek cancer treatment, heart surgery, orthopedics, neurological care and treatment for children.
India offers lower prices than many Western countries.
It also has hospitals used to serving Arabic-speaking families.
But the journey can be difficult.
Flights may require connections.
Visas and documents can be hard to arrange.
Families may not have access to normal banking.
A patient may arrive after months of delay.
The medical case can be more advanced by then.
Yemen’s current numbers may be lower than before the pandemic.
It remains an important patient road because the need has not disappeared.
India Is Not Selling a Quick Makeover
India’s medical tourism brand is less glamorous than Korea’s.
It is less visible than Turkey’s.
It does not produce as many before-and-after videos.
That is because many Indian medical travelers do not want to show their treatment online.
A cancer patient does not film a fun airport reel.
A parent bringing a child for heart surgery is not making holiday content.
The business happens in private messages.
Medical reports are sent.
Doctors review scans.
Families ask for the price.
A hospital sends an invitation letter.
The patient applies for a medical visa.
The main treatments named by the Indian government include cardiac surgery, orthopedics, cancer care, organ transplants, neurological treatment, cosmetic surgery, dentistry and fertility care.
This makes India’s market harder to advertise.
It also makes it harder to replace.
A low-cost dental clinic can open in many countries.
A large transplant or cancer center takes years to build.
India’s advantage is not one famous treatment.
It is the number of serious treatments it can offer.
Delhi Is the Main Door
Delhi is the center of India’s international hospital business.
It has major private hospital groups.
It has many flights.
It has embassies.
It has large communities of patient agents and translators.
The government’s own summary of internationally accredited hospitals showed Delhi ahead of Mumbai, Bengaluru, Chennai, Hyderabad, Ahmedabad, Kolkata and Kochi.
Patients from Iraq, Central Asia and Africa often use Delhi.
The city has Arabic, Russian and African patient networks.
Apartment buildings near some hospitals have become recovery homes.
Restaurants change menus for foreign families.
Drivers learn hospital routes.
Pharmacies know which medicines international patients need.
The medical tourism system exists outside the hospital walls.
A skilled surgeon may bring the patient.
The neighborhood helps the family stay.
Kolkata Lives on the Bangladesh Road
Kolkata’s medical travel story is much narrower.
It is tied to Bangladesh.
That is its strength.
It is also its danger.
The city is close to the border.
The language is shared.
Food feels familiar.
Families can travel without crossing half of India.
Before the political and visa crisis, some Kolkata hospitals treated thousands of Bangladeshi patients each month.
When visa services slowed, patient numbers at several hospitals fell sharply. In early 2026, hospitals began reporting more inquiries again as access started to improve.
Kolkata shows what happens when a city builds its medical tourism business around one country.
The system can grow very fast.
It can also fall very fast.
Chennai Built the Old Hospital Model
Chennai was selling international hospital care before medical tourism became a popular phrase.
Its private hospitals built names in heart care, orthopedics, organ transplants and children’s medicine.
Patients arrived from Bangladesh, Sri Lanka, Maldives, East Africa and the Gulf.
The city’s offer was simple.
Strong doctors.
Large hospitals.
Lower costs.
English service.
Less waiting.
Chennai may not have Delhi’s political reach or Mumbai’s global image.
It has years of treatment history.
That matters when families choose a hospital through word of mouth.
A doctor’s name may travel across borders long before the hospital buys an advertisement.
India’s Hidden Product Is English
Price gets most of the attention.
Language may be just as important.
English is the main language of medical education and clinical work in many Indian hospitals. The Indian government lists this as one of the country’s core advantages in medical travel.
That helps patients from Kenya, Nigeria, Uganda and other English-speaking markets.
It helps international insurance companies.
It helps doctors read foreign medical records.
It helps a family understand the treatment plan.
English does not solve every language problem.
Patients from Iraq still need Arabic.
Patients from Uzbekistan may need Russian or Uzbek.
Bangladeshi patients may want Bengali.
But the doctor can often speak directly to international partners without waiting for every word to be translated.
That can save time in serious cases.
Cheap Does Not Always Mean Simple
India’s prices can be far below those in the United States, Britain, Singapore or the Gulf.
The government says complex treatment is often available at a much lower cost while using modern medical technology.
But the final bill can still surprise a patient.
The first estimate may cover surgery.
Then the patient needs more days in intensive care.
A complication appears.
More tests are ordered.
The family extends the hotel.
New medicines are added.
The flight home is changed.
A $10,000 treatment can become a $15,000 trip.
That may still be cheaper than care in a rich country.
For a family from Somalia or Bangladesh, it can be financially devastating.
Hospitals and agents often sell the starting price.
Families live with the final price.
India Has a Quality Gap
India has some of the best private hospitals in the region.
It also has thousands of facilities with very different standards.
The government reported more than 69,000 hospitals across the country. As of 2026, more than 1,299 had received accreditation from the National Accreditation Board for Hospitals and Healthcare Providers.
That does not mean every hospital without accreditation is unsafe.
It does mean patients must check.
Who is the doctor?
Who owns the hospital?
Is the facility accredited?
Who handles emergencies?
Is the price from the hospital or from an agent?
What happens after the patient returns home?
These questions matter more than the hotel or airport pickup.
A good coordinator can save a family from a bad choice.
A bad coordinator can place commission above care.
India’s own medical tourism plan calls for stronger registration and rating of facilitators. That is a sign that the middleman problem has not been fully solved.
The Patient May Become Trapped Between the Hospital and Agent
Many international patients do not contact a hospital directly.
They contact a medical travel company.
The company collects the reports.
It recommends a doctor.
It sends a price.
It helps with visas and travel.
This can be useful.
India is large and confusing.
A sick visitor needs help.
But the patient may not know how the agent is paid.
One hospital may pay a higher commission than another.
The recommended doctor may not be the best doctor.
The agent may add fees without showing them.
The patient may believe they are speaking to the hospital when they are not.
The best system makes the relationship clear.
The hospital gives the medical plan.
The facilitator handles travel.
The patient knows who is responsible for each part.
Too often, those lines are blurred.
The Numbers Still Need Care
India counted 507,244 foreign arrivals for medical purposes in 2025.
That does not always mean 507,244 different people received one treatment each.
The data records arrivals.
A patient may enter India more than once.
A transplant patient may return for follow-up care.
A cancer patient may make several trips.
A person may enter on a medical visa but receive more than one service.
The market-value estimate also includes more than hospital bills.
Families spend money on hotels, food, transport, medicines and helpers.
Wellness travel can also be counted inside the wider medical tourism economy.
That helps explain why India’s estimated $8.7 billion market looks very large compared with the official arrival count.
The industry is real.
The exact size depends on what is counted.
Ayurveda Is a Different Patient Road
Modern hospitals are only half of India’s health travel story.
India also sells Ayurveda, yoga, naturopathy and other traditional systems grouped under AYUSH.
These visitors may not be sick.
They may want rest.
Weight loss.
Pain relief.
Stress care.
A long wellness stay.
The government introduced a special AYUSH visa in 2023 and now offers medical and medical-attendant e-visas to citizens of 172 countries.
Kerala is central to this business.
Its wellness centers combine treatment, food, nature and long stays.
This is closer to Thailand’s wellness model than Delhi’s hospital model.
The patient is not choosing between heart surgeons.
They are choosing how they want to feel.
India has a rare chance to sell both.
Advanced surgery in one city.
Traditional wellness in another.
But the two products should not be mixed carelessly.
A yoga retreat is not cancer treatment.
A massage center is not a hospital.
The patient must know which one they are buying.
India Is Building a Bigger Machine
The Indian government wants the medical travel journey to become easier.
The 2026–27 budget proposed five regional medical hubs.
The plan includes advanced hospitals, education, research, rehabilitation, AYUSH centers and medical travel support in the same areas.
The government also plans airport help desks and medical travel lounges to guide patients through immigration, customs and baggage collection.
This sounds small next to a heart operation.
It is not.
A foreign patient can feel lost before leaving the airport.
They may not have mobile data.
They may not know where the driver is.
They may be weak, in pain or traveling with a sick child.
The medical journey begins before the hospital.
Turkey understood this early.
Thailand understood it early.
India has often focused on the doctor and left the rest to agents.
The new plan tries to fix that.
India Is Really Running Four Medical Tourism Businesses
India’s patient map looks messy until it is divided into four roads.
The Bangladesh road
This is the volume business.
Patients come because India is close, known and cheaper than many other foreign choices.
Kolkata, Chennai and Delhi benefit.
The market is huge but exposed to politics.
The Middle East road
This includes Iraq, Oman and Yemen.
The cases are often complex.
Families may stay for weeks.
Arabic service, trust and hospital skill matter.
The Central Asia road
This includes Uzbekistan and Turkmenistan, with Kazakhstan and other nearby countries behind them.
The market is growing fast.
India competes with Turkey, Russia, Germany and South Korea.
The Africa road
This includes Somalia, Kenya, Nigeria, Tanzania and Uganda.
The need is large.
The patients often require serious care.
The main barriers are flights, payment, visas and follow-up treatment.
India needs all four roads.
Bangladesh brings scale.
The Middle East brings complex cases.
Central Asia brings growth.
Africa brings the future.
The Fall in 2025 Was a Warning
India received 644,387 medical-purpose arrivals in 2024.
The number fell to 507,244 in 2025.
That was a decline of more than 21 percent.
Most of that loss came from Bangladesh.
This is both bad and useful.
It exposed the weakness early.
India now knows it cannot build its entire international patient system around one border.
Hospitals are looking harder at Africa.
They are building links in Central Asia.
They are trying to win more Gulf patients.
They are using online second opinions to reach families before another country does.
The next stage of India’s medical tourism growth may not come from adding more Bangladeshi patients.
It may come from becoming less dependent on them.
What India’s Patient Map Tells Us
India did not become a medical tourism power because it made healthcare look fun.
It became powerful because it made hard treatment possible.
A family could not afford surgery in London.
India offered another price.
A child could not receive complex heart care at home.
India offered another hospital.
A cancer patient had waited too long.
India offered another path.
That is the real Indian product.
Not a beach.
Not a new face.
Not a luxury recovery suite.
A second chance.
But a second chance must still be safe.
The hospital must be checked.
The doctor must be checked.
The cost must be clear.
The patient must know what happens after going home.
India already has the doctors.
It already has the hospitals.
It already has hundreds of thousands of foreign patients.
Its next challenge is trust.
Not the kind of trust created by an advertisement.
The kind created when a frightened family arrives with a folder of scans—and knows exactly who will help them next.
